It has been demonstrated that upregulation of CHEK1 can ameliorate the overall survival of non-small-cell lung cancer patients and miR-195 downregulates the expression level of CHEK1, which inhibits cell migration, growth, or invasion [65]. This evidence concerns the gene CHEK1 and non-small cell lung carcinoma.